Classification of Osteogenesis Imperfecta revisited

Baldridge, 2008, CRTAP and LEPRE1 mutations in recessive osteogenesis imperfecta, Hum. Mutat., 29, 1435, 10.1002/humu.20799

Barnes, 2006, Deficiency of cartilage-associated protein in recessive lethal osteogenesis imperfecta, N. Engl. J. Med., 355, 2757, 10.1056/NEJMoa063804

Bauze, 1975, An new look at osteogenesis imperfecta: a clinical, radiological and biochemical study of forty-two patients, J. Bone Joint Surg., 57-B, 1415, 10.1302/0301-620X.57B1.2

Byers, 1992, Osteogenesis imperfecta, Annu. Rev. Med., 43, 269, 10.1146/annurev.me.43.020192.001413

Byers, 1991, Osteogenesis Imperfecta: translation of mutation to phenotype, J. Med. Genet., 28, 433, 10.1136/jmg.28.7.433

Cabral, 2007, Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta, Nat. Genet., 39, 359, 10.1038/ng1968

Cobben, 1990, Prevalence of lethal osteochondrodysplasias, AJMG, 36, 377, 10.1002/ajmg.1320360338

F. van Dijk, I. Nesbitt, P. Nikkels, A. Dalton, E. Bongers, J. van de Kamp, Y. Hilhorst-Hofstee, N. den Hollander, A. Lachmeijer, C. Marcelis, M. Tan-Sindhunata, R. van Rijn, H. Meijers-Heijboer, J. Cobben, G. Pals, CRTAP mutations in lethal and severe osteogenesis imperfecta: the importance of combining biochemical and molecular genetic analysis, EJHG, Epub ahead of print.

F. van Dijk, I. Nesbitt, E. Zwikstra, P. Nikkels, S. Piersma, S. Fratantoni, C. Jimenez, M. Huizer, A. Morsman, J. Cobben, M. van Roij, M. Elting, J. Verbeke, L. Wijnaendts, N. Shaw, W. Högler, C. McKeown, E. Sistermans, A. Dalton, H. Meijers-Heijboer, G. Pals, PPIB mutations cause severe osteogenesis imperfecta, AJHG, Epub ahead of print.

Fleming, 2005, Cyclic biphosphonate therapy in osteogenesis imperfecta type V, J. Paediatr. Child Health, 41, 147, 10.1111/j.1440-1754.2005.00567.x

Glorieux, 2000, Type V osteogenesis imperfecta: a new form of brittle bone disease, J. Bone Miner. Res., 15, 1650, 10.1359/jbmr.2000.15.9.1650

Glorieux, 2002, Osteogenesis imperfecta type VI: a form of brittle bone disease with mineralization defect, J. Bone Miner. Res., 17, 30, 10.1359/jbmr.2002.17.1.30

Labuda, 2002, Osteogenesis imperfecta type VII maps to the short arm of chromosome 3, Bone, 31, 19, 10.1016/S8756-3282(02)00808-6

Land, 2007, Osteogenesis imperfecta type VI in childhood and adolescence: effects of cyclical intravenous pamidronate treatment, Bone, 40, 638, 10.1016/j.bone.2006.10.010

Lee, 2006, Clinical and radiological manifestations of osteogenesis imperfecta, J. Korean Med. Sci., 21, 709, 10.3346/jkms.2006.21.4.709

Marini, 2007, Components of the collagen prolyl-3-hydroxylation complex are crucial for normal bone development, Cell Cycle, 6, 1675, 10.4161/cc.6.14.4474

Marini, 2007, Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sides for integrins and proteins, Hum. Mutat., 28, 209, 10.1002/humu.20429

Marini, 1989, Osteogenesis imperfecta type IV. Detection of a point mutation in one alpha1(I) collagen allele (Col1a1) by RNA/RNA hybrid analysis, J. Biol. Chem., 264, 11893, 10.1016/S0021-9258(18)80150-8

Morello, 2006, CRTAP is required for prolyl 3-hydroxylation and mutations cause autosomal recessive osteogenesis imperfecta, Cell, 127, 291, 10.1016/j.cell.2006.08.039

Obafemi, 2008, Popcorn calcifications in osteogenesis imperfecta: incidence, progression, and molecular correlation, AJMG, 146A, 2725

Online Mendelian Inheritance in Man, OMIM (TM). Johns Hopkins University, Baltimore, MD. MIM number:{ #610915}: {7/14/2008} and MIM number:{ #610854}:{3/19/2007}: World Wide Web URL: http://www.ncbi.nlm.nih.gov/omim/

Rauch, 2004, Osteogenesis imperfecta, Lancet, 363, 1377, 10.1016/S0140-6736(04)16051-0

Sillence, 1984, Osteogenesis imperfecta type II delineation of the phenotype with reference to genetic heterogeneity, Am. J. Med. Genet., 17, 407, 10.1002/ajmg.1320170204

Sillence, 1979, Genetic heterogeneity in osteogenesis imperfecta, J. Med. Genet., 16, 101, 10.1136/jmg.16.2.101

Spranger, 2003, Section X: skeletal dysplasias with prominent diaphyseal involvement, Osteogenesis imperfecta, type III/ IIB, 440

R. Steiner, M. Pepin, P. Byers, Osteogenesis Imperfecta.www.genetests.com

Wallis, 1993, Osteogenesis imperfecta type III: mutations in the type I collagen structural genes, COL1A1 and COL1A2, are not necessarily responsible, J. Med. Genet., 30, 492, 10.1136/jmg.30.6.492

Ward, 2002, Osteogenesis Imperfecta type VII an autosomal recessive form of brittle bone disease, Bone, 31, 12, 10.1016/S8756-3282(02)00790-1

Zeitlin, 2006, The effect of cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta type V, Bone, 38, 13, 10.1016/j.bone.2005.07.020